Meclizine 12.5 mg Oral Lozenge
RxNorm 995753
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 995753 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: meclizine 12.5 mg Oral Lozenge.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Meclizine hydrochloride 12.5 mg Oral Lozenge
(Atom ID: 12348894)
PSN
Prescribable Name (PSN):
Meclizine 12.5 mg Oral Lozenge
(Atom ID: 6363284)
PT
Designated preferred name (PT):
Meclizine hydrochloride 12.5 mg oromucosal lozenge
(Atom ID: 11437511)
SY
Synonym (SY):
Meclozine hydrochloride 12.5 mg oromucosal lozenge
(Atom ID: 11437514)
FN
Full form of descriptor (FN):
Product containing precisely meclozine hydrochloride 12.5 mg/1 each conventional release oromucosal lozenge (clinical drug)
(Atom ID: 11440267)
Patient Education
Meclizine
Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.
[Learn More]
* Please review the disclaimer below.